GlaxoSmithKline: Uterine Cervical Dysplasia trials

The registry lists 10 Uterine Cervical Dysplasia studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 1 1Phase 2 1Phase 3 5Phase 4 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of AgeCompletedNCT05496231Phase 1/2Results posted
• Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 StudyCompletedNCT03629886Phase 4Results posted
• A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese SubjectsCompletedNCT03438006Results posted
• A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 StudyCompletedNCT03355820Phase 3Results posted
• Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 StudyCompletedNCT00929526Phase 3Results posted
• Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult WomenCompletedNCT00337818Phase 3Results posted
• Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 VaccineCompletedNCT00316706Phase 3Results posted
• Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy ParticipantsCompletedNCT00128661Phase 3Results posted
• Indirect Comparison Topotecan Cervical CarcinomaCompletedNCT01345279
• Meta-analysis of Efficacy of TopotecanCompletedNCT01160185